Found: 6
Select item for more details and to access through your institution.
Validation of the UK myeloma research alliance risk profile, a new clinical prediction model for outcome in patients with newly diagnosed multiple myeloma not eligible for autologous stem cell transplantation; a population‐based study from the Danish national multiple myeloma registry
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 1, p. 119, doi. 10.1111/bjh.16806
- By:
- Publication type:
- Article
Evaluation of the serum free light chain (sFLC) analysis in prediction of response in symptomatic multiple myeloma patients: rapid profound reduction in involved FLC predicts achievement of VGPR.
- Published in:
- European Journal of Haematology, 2014, v. 93, n. 5, p. 407, doi. 10.1111/ejh.12376
- By:
- Publication type:
- Article
First-line treatment with bortezomib rapidly stimulates both osteoblast activity and bone matrix deposition in patients with multiple myeloma, and stimulates osteoblast proliferation and differentiation in vitro.
- Published in:
- European Journal of Haematology, 2010, v. 85, n. 4, p. 290, doi. 10.1111/j.1600-0609.2010.01485.x
- By:
- Publication type:
- Article
Prognostic significance of infectious episodes occurring during first-line therapy for diffuse large B-cell lymphoma - A nationwide cohort study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Causes of early death in multiple myeloma patients who are ineligible for high-dose therapy with hematopoietic stem cell support: A study based on the nationwide Danish Myeloma Database.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 4, p. E73, doi. 10.1002/ajh.23932
- By:
- Publication type:
- Article
Immunoparesis in newly diagnosed Multiple Myeloma patients: Effects on overall survival and progression free survival in the Danish population.
- Published in:
- PLoS ONE, 2017, v. 12, n. 12, p. 1, doi. 10.1371/journal.pone.0188988
- By:
- Publication type:
- Article